The BioProcess Insider Expression Platform – Détails, épisodes et analyse

Détails du podcast

Informations techniques et générales issues du flux RSS du podcast.

The BioProcess Insider Expression Platform

Dan Stanton

Sciences

Business & Entrepreneuriat

Fréquence : 1 épisode/43j. Total Éps: 31

From business publication BioProcess International comes The BioProcess Insider Expression Platform (BIEP). Editor Dan Stanton takes a look beyond the nuts and bolts of the biomanufacturing industry and speaks to some of the pioneers and thought leaders turning production on its head. www.bioprocessinsider.com

Lire plusRéduire

Site

RSS

Apple

Classements récents

Dernières positions dans les classements Apple Podcasts et Spotify.

Apple Podcasts

🇬🇧 Grande Bretagne - lifeSciences
08/03/2026
#94
🇬🇧 Grande Bretagne - lifeSciences
07/03/2026
#70
🇬🇧 Grande Bretagne - lifeSciences
06/03/2026
#58
🇬🇧 Grande Bretagne - lifeSciences
05/03/2026
#44

Liens partagés entre épisodes et podcasts

Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.

https://twitter.com/BioProInsider
3 partages
https://twitter.com/BioProcessIntl
3 partages
https://twitter.com/Dan5tanton
3 partages

https://podcasts.apple.com/fr/podcast/the-bioprocess-insider-expression-platform/id1549869188
4 partages

Qualité et score du flux RSS

Évaluation technique de la qualité et de la structure du flux RSS.

Qualité du flux RSS

À améliorer

Score global : 42%

Historique des publications

Répartition mensuelle des publications d'épisodes au fil des années.

Year

Derniers épisodes publiés

Liste des épisodes récents, avec titres, durées et descriptions.

Podcast: Sustainability is about health equity, says ScaleReady and Germfree

Épisode 31

mardi 6 août 2024 • Durée 26:27

ScaleReady and Germfree discuss the need to rethink sustainability and move towards a more standardized and simplistic manufacturing model to ensure health equity can be achieved.

This episode of our monthly podcast Voices of Biotech brings you an interesting conversation with Carol Houts, chief strategy officer at Germfree and Josh Ludwig, global director commercial operations at ScaleReady.

Together, they discuss how sustainability measures can increase patient care and access through decentralized manufacturing models, which can reduce the time, space, and cost associated with producing cell and gene therapies (CGTs) and other modalities.

The conversation about sustainability leads into a discussion about the ecosystem in the life sciences space.

While both acknowledged and spoke in-depth about the advantages of educating the industry and shifting towards a more decentralized manufacturing model, Ludwig and Houts did not shy away from discussing some of the challenges the industry faces. These include the shortage of talent in the space, the element of many players still “figuring it out” as sustainability is not an individual issue but a collective one, and the issue of drug shortages.

The pair ended the podcast with some thought-provoking statements regarding the need to rethink what sustainability means and urged how standardization is really the key to achieving better patient care and access.

The latest episode can be found here or through the BioProcess Insider Expression Platform at, Spotify, Apple iTunes, Google podcasts, or wherever you get your podcasts.

Lire plusRéduire

Podcast: Sustainability at events is environmental and humanistic, says EBD

Épisode 30

jeudi 27 juin 2024 • Durée 52:13

Life Sciences partnering events company EBD Group discusses the importance of communication, education, and the trials and tribulations of organizing an event with sustainability in mind.

This episode of our monthly podcast Voices of Biotech brings you a slightly different conversation in this series about sustainability with Claire Macht, portfolio director, Europe and Manuela Hildebrand, regional delivery director, both from the EBD Group.

Together, they discuss how sustainability measures are implemented from an operational standpoint at conferences such as reuseable booths, less food and beverage wastage, more plant-based/vegetarian options, and even the much-debated topic of carpet or no carpet in the exhibition hall.

Additionally, Macht and Hildebrand discuss how and why sustainability is also tackled from a wellbeing perspective at EBD events. For example, providing attendees with healthier food and drink options, a massage booth, lounges to relax, fun runs, and more.

While both acknowledged and spoke in-depth about the need to educate and communicate with attendees and staff members on why certain decisions have been made to create a “buy-in” mentality, Macht and Hildebrand did not shy away from some of the challenges the team faces when planning an event with sustainability and the FasterForward initiative at the forefront.

EBD’s next partnering-focused event is ChinaBIO, taking place in Shanghai, China September 10-11th, or virtually on September 16-17th. Two months later, BIO-Europe will take place in Stockholm, Sweden on November 4-6th.

The latest episode can be found here or through the BioProcess Insider Expression Platform at, Spotify, Apple iTunes, , or wherever you get your podcasts.

Voices of Biotech Episode 4: Bristol Myers Squibb on the limited diversity of the hiring pool

Épisode 21

mercredi 10 mai 2023 • Durée 28:24

When it comes to hiring, there is not enough diversity at upper leadership levels says Bristol Myers Squibb’s Executive Director.

In the next episode of Voices of Biotech, brought to you by BioProcess Insider Expression Platform, Vibha Jawa, Executive Director of Bristol Myers Squibb discusses the limited diversity of the hiring pool, building a network of female professionals, and career mentorship.

Jawa shares her career journey and the challenges in transitioning from academia to industry. “There is always a mindset that people from academia are not made for biotech or the pharmaceutical sector. So, it took me a while to get out of that academic mode,” says Jawa.

This leads her to highlight the importance of mentoring and developing a strong network of support at the beginning of your career, “I could’ve benefited initially with a better network which I did not have.”

Jawa moves on to discuss diversity in leadership. Whilst this has improved on a graduate level, “if I'm looking for someone who can do a role where they manage a bigger group, I don't find the diversity. I don't even find it in the job pool,” says Jawa.

Lire plusRéduire

Voices of Biotech Episode 3: From farm to pharma, meet Terumo’s CEO

Épisode 20

mardi 11 avril 2023 • Durée 36:41

This episode of the Voices of Biotech - brought to you by the BioProcess Insider Expression Platform -brings you an in-depth conversation with Antoinette Gawin, CEO of Terumo Blood and Cell Technologies.

Gawin shares her personal experience of growing up within an immigrant farming community before entering the pharma space and climbing the career ladder. She talks about how people should not be afraid to show vulnerability in the workplace. Additionally, she discusses the importance of making sure all voices are heard, regardless of who the voices come from.

We discuss women in the life sciences space, diversity and inclusion, and how this cannot be seen as a task but must be part of your company culture to truly anchor value, employee wellbeing and successful performance. The conversation also delves into how there a perception that when a woman brings an idea to the space, there is still an aspect of risk associated with this.

Lire plusRéduire

Voices of Biotech 2: Bayer on why female role models matter

Épisode 19

mercredi 8 mars 2023 • Durée 21:34

“Women and people of diverse backgrounds remain underrepresented in the upper echelons of the biopharma c-suite,” says Ilona Gutcher, director of BD&L Oncology at Bayer.

Aligning with International Women’s Day (Wednesday 8th March) the BioProcess Insider Expression Platform has released its second episode of Voices of Biotech.

“I wouldn’t be here without the I&D Xcelerate program,” says Gutcher, another graduate of the Bayer program launched by Marianne De backer two years ago to promote diversity through a 6–9 month placement within Business Development & Licensing and Open Innovation (BD&L/OI) department.

She discusses her experience with the initiative and beyond, advocating for mentorship programs. and stressing the importance of having female role-models in C-suite positions to encourage women to reach their full potential.

Gutcher ends by saying Bayer has committed to achieve gender parity on each management level by 2030 and has plans to expand the I&D Xcelerate program to other divisions within the company.

Lire plusRéduire

Voices of Biotech Episode 1: Bayer’s Deepa Talpade on driving life science diversity

Épisode 18

vendredi 10 février 2023 • Durée 40:41

With the celebration of International Day of Women and Girls in Science on 11th February 2023, we are excited to announce Informa’s latest podcast series produced on the BioProcess Insider Expression Platform (BIEP), where we dive into the complex journey of key female leaders shaping the life science industry.

Despite the progress over the last decade, gender parity remains a global issue throughout all levels within the science, technology, engineering, and mathematics (STEM) disciplines. Within academia, only 33.3% of all researchers are women, dwindling to a further 12% making national science academies. It is important to question how the industry is evolving, what progress has been made, and what steps we need to take next. This podcast will celebrate women and minorities in science and what more can be done to amplify their voices.

In this first episode of Voices of Biotech, we are joined by Deepa Talpade, VP, BD&L and Strategic Alliances of Oncology at Bayer who discusses the success of Bayer’s I&D Xcelerate program, launched by Marianne De backer two years ago, which promotes diversity through a 6–9-month placement within Bayer’s BD&L department.

Deepa also touches upon the socioeconomic impact deterring women to reach their full potential, the necessity to take a risk on women and the need for authenticity in leadership roles: “we should be allowed to colour ourselves in the way that we choose to”.

Lire plusRéduire

Ori Biotech: CGT accessibility, from platform to patient

Épisode 17

jeudi 5 janvier 2023 • Durée 33:57

This episode of the BioProcess Insider Expression Platform (BIEP) podcast brings you an in-depth conversation with Jason Foster, CEO of Ori Biotech. The company experienced a year of transition in 2022 with the closing of its $100 million Series B funding round and the expansion of its paperless cell and gene therapy (CGT) platform.

Foster speaks about the current process of taking the platform from clinical to commercial through feedback derived from its LightSpeed Early Access Program (LEAP) partners. He also discusses the issues surrounding accessibility, pricing, and supply chain fragility in the advanced therapies space.

The conversation moves on to talk about advanced therapies as both first and second-line treatments, in which Foster speaks about the hurdles created by the EU and US healthcare systems.

Lire plusRéduire

Ireland’s in the (up/down) stream: NIBRT talks bioproduction

Épisode 16

jeudi 17 novembre 2022 • Durée 22:42

The latest edition of the BioProcess Insider Expression Platform has NIBRT’s Killian O'Driscoll speaking on Ireland’s robust biomanufacturing environment, training programs, and vendor-led technologies.

Ireland has long established itself as a drug manufacturing hub and is home to commercial production sites run by Big Pharma firms including Pfizer, J&J, Eli Lilly, and AstraZeneca, as well as numerous third-party manufacturing organizations and bioprocess vendor firms.

The business environment has been spurred by low corporate tax rates, but also a highly skilled workforce, which has been supported by the government-funded National Institute for Bioprocessing Research and Training (NIBRT). The Dublin institution has been described as a ‘flight simulator for biomanufacturing,’ and has trained over 4,000 people a year in bioproduction processes since it opened in 2011.

At Biotech Week Boston in September, BioProcess Insider caught up with Killian O'Driscoll, director of Projects at NIBRT, who spoke to us in depth about Ireland’s pharma heritage, NIBRT’s international presence, and its relationship with vendors.

Lire plusRéduire

Securing a CDMO with Pharmatech Associates (a CPhI WW preview)

Épisode 15

lundi 12 septembre 2022 • Durée 31:28

Bikash Chatterjee and Stephanie Gaulding, CEO and MD at drug development consultancy firm Pharmatech Associates, talk about the different partnering and outsourcing strategies innovators can take, with a specific focus on smaller and mid-sized biotechs, which often don’t have the same level of in-built CMC expertise as Big Pharma. Whether you go with a single end-to-end CDMO or a multi-model approach, one thing is clear: know your product, know your needs and plan early.

This conversation originally took place as a Linkedin Live event ahead of the CPhI Worldwide conference happening in Frankfurt in November.

Lire plusRéduire

Turning out talent and the trials of training with Stuart Curbishley and Ivan Wall

Épisode 14

vendredi 12 août 2022 • Durée 37:30

This episode of the BioProcess Insider Expression Platform (BIEP) podcast brings you an in-depth conversation with Stuart Curbishley, head of business and project development, advanced therapies at University of Birmingham and Ivan Wall, CEO, Four-Plus and director of the National Training Center for advanced therapies manufacturing.

We delve deep into the challenges concerning training talent in the advanced therapy and wider biopharma space, potential solutions that could filter the staffing bottleneck, and how the respective institutions are responding to these issues.

Lire plusRéduire

Podcasts Similaires Basées sur le Contenu

Découvrez des podcasts liées à The BioProcess Insider Expression Platform. Explorez des podcasts avec des thèmes, sujets, et formats similaires. Ces similarités sont calculées grâce à des données tangibles, pas d'extrapolations !

Il n'y a pas de contenu associé à ce podcast.

À propos Méthodologie Contact Me soutenir Politique de confidentialité

The BioProcess Insider Expression Platform – Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Liens partagés entre épisodes et podcasts

Other14

Twitter3

Apple Podcast1

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts et contenus similaires

Podcasts Similaires Basées sur le Contenu

Podcasts Similaires Basées sur le Contenu

Other14

Twitter3

Apple Podcast1

Apple Podcasts

Spotify